Inter-strain heterogeneity in rat hepatic transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)  by Yao, Cindy Q. et al.
Toxicology and Applied Pharmacology 260 (2012) 135–145
Contents lists available at SciVerse ScienceDirect
Toxicology and Applied Pharmacology
j ourna l homepage: www.e lsev ie r .com/ locate /ytaapInter-strain heterogeneity in rat hepatic transcriptomic responses to
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
Cindy Q. Yao a, Stephenie D. Prokopec a, John D. Watson a, Renee Pang a, Christine P'ng a, Lauren C. Chong a,
Nicholas J. Harding a, Raimo Pohjanvirta c,d, Allan B. Okey e, Paul C. Boutros a,b,⁎
a Informatics and Biocomputing Platform, Ontario Institute for Cancer Research, Toronto, Canada
b Department of Medical Biophysics, University of Toronto, Toronto, Canada
c Laboratory of Toxicology, National Institute for Health and Welfare, Kuopio, Finland
d Department of Food Hygiene and Environmental Health, University of Helsinki, Finland
e Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada⁎ Corresponding author at: MaRS Centre, South Towe
Ontario, Canada M5G 0A3. Fax: +1 416 673 8564.
E-mail address: Paul.Boutros@oicr.on.ca (P.C. Boutro
0041-008X © 2012 Elsevier Inc.
doi:10.1016/j.taap.2012.02.001
Open access under CC BYa b s t r a c ta r t i c l e i n f oArticle history:
Received 8 November 2011
Revised 30 January 2012
Accepted 1 February 2012
Available online 9 February 2012
Keywords:
TCDD
Dioxin
Aryl hydrocarbon receptor
mRNA abundance
Time-course study
Microarray
Real-time RT-PCRThe biochemical and toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) have been the subject of intense
study for decades. It is now clear that essentially all TCDD-induced toxicities aremediated by DNA–protein inter-
actions involving the Aryl Hydrocarbon Receptor (AHR). Nevertheless, it remains unknown which AHR target
genes cause TCDD toxicities. Several groups, including our own, have developed rodent model systems to
probe these questions. mRNA expression proﬁling of these model systems has revealed signiﬁcant inter-
species heterogeneity in rodent hepatic responses to TCDD. It has remained unclear if this variability also exists
within a species, amongst rodent strains. To resolve this question, we proﬁled the hepatic transcriptomic re-
sponse to TCDD of diverse rat strains (L-E, H/W, F344 and Wistar rats) and two lines derived from L-E×H/W
crosses, at consistent age, sex, and dosing (100 μg/kg TCDD for 19 h). Using this uniquely consistent dataset,
we show that the majority of TCDD-induced alterations in mRNA abundance are strain/line-speciﬁc: only 11
genes were affected by TCDD across all strains, including well-known dioxin-responsive genes such as Cyp1a1
and Nqo1. Our analysis identiﬁed two novel universally dioxin-responsive genes as well as 4 genes induced by
TCDD in dioxin-sensitive rats only. These 6 genes are strong candidates to explain TCDD-related toxicities, so
we validated them using 152 animals in time-course (0 to 384 h) and dose–response (0 to 3000 μg/kg) experi-
ments. This study reveals that different rat strains exhibit dramatic transcriptional heterogeneity in their hepatic
responses to TCDD and that inter-strain comparisons can help identify candidate toxicity-related genes.
© 2012 Elsevier Inc.Open access under CC BY-NC-ND license.Introduction
Chlorinated dioxins are a large class of environmental contami-
nants produced by industrial processes ranging from incineration,
recycling of electronics, pesticide manufacturing and paper bleaching
(Schecter et al., 2006). Dioxins cause a wide variety of toxic effects
and are the subject of intense study due to concerns around wide-
spread human exposures, particularly through the ingestion of contam-
inated food (Pohjanvirta and Tuomisto, 1994). While the outcomes of
exposure in humans are controversial and difﬁcult to determine,
short-term dioxin toxicities in adult laboratory animals include hepatic
lesions, endocrine and immune imbalances, body wasting, augmented
oxidative stress, and acute lethality (reviewed in Pohjanvirta and
Tuomisto, 1994).r, 101 College Street, Toronto,
s).
-NC-ND license.Most studies of dioxins have focused on the most potent and toxic
congener, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Although the
mechanisms of dioxin toxicity have not been fully elucidated, several
key steps common to all members of this chemical family are known.
Many studies show that the toxicity of TCDD, related halogenated ar-
omatic hydrocarbons, and polycyclic aromatic hydrocarbons (PAHs)
is mediated by a ligand-activated transcription factor — the aryl hy-
drocarbon receptor (AHR) (Bunger et al., 2003; Okey, 2007;
Walisser et al., 2004). This mechanism is sometimes referred to as
the “classic action pathway”. In the absence of an appropriate ligand,
the AHR sits quiescent in the cytoplasm in a complex of proteins that
includes heat-shock protein 90, p23 and X-associated protein 2
(Furness et al., 2007; Harper et al., 2006; Petrulis and Perdew,
2002). Ligand-binding triggers a conformational change, leading the
complex to translocate to the nucleus and dissociate (Lin et al.,
2007; McMillan and Bradﬁeld, 2007). Nuclear AHR then forms a het-
erodimer with the aryl hydrocarbon receptor nuclear translocator
(ARNT) (Reyes et al., 1992). The AHR:ARNT complex then recognizes
and binds to DNA response element called AHRE-I and AHRE-II (Aryl
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of genes such as Cyp1a1 (Boutros et al., 2008; Lusska et al., 1993;
Mimura and Fujii-Kuriyama, 2003).
Several lines of evidence prove that the aryl hydrocarbon receptor
(AHR) is essential for TCDD toxicity. First, when the AHR is genetically
knocked out in mice, they demonstrate exceptional resistance to
TCDD-induced toxicities, including acute lethality, thymic atrophy,
main features of the liver lesion, teratogenicity (cleft palate and
hydronephrosis), developmental toxicity to male reproductive organs,
reduced plasma thyroxin levels, disrupted vitamin A homeostasis, por-
phyria, and immune toxicity (humoral and cell-mediated immune reac-
tions) (Davies et al., 2008; Fernandez-Salguero et al., 1995; Lin et al.,
2002; Mimura and Fujii-Kuriyama, 2003; Nishimura et al., 2005;
Schmidt et al., 1996; Vorderstrasse et al., 2001). They are also refractory
to transcriptional responses (Boutros et al., 2009; Tijet et al., 2006). Sec-
ond, micewithmutations in the AHR that prevent nuclear translocation
(Bunger et al., 2003) or binding to AHREs (Bunger et al., 2008) were
non-responsive to all impacts of TCDD examined including hepatomeg-
aly and thymic atrophy. Finally, mice hypomorphic for ARNT exhibited
attenuated thymic atrophy and hepatotoxicity but unaffected Cyp1a1
induction (Walisser et al., 2004). Taken together, these data suggest
that DNA-binding of the ligand-activated AHR:ARNT complex is essen-
tial for major toxic outcomes of TCDD.
Beyond transgenic mice, several other model systems have been
used to study dioxin toxicity. Of particular importance, Long-Evans
(Turku A/B) (L-E) and Han/Wistar (Kuopio) (H/W) rats have been ex-
tensively exploited in mechanistic studies because of their striking
differential susceptibilities to TCDD toxicity. L-E rats are sensitive to
TCDD,with an LD50 of 10–20 μg/kg (Pohjanvirta et al., 1993). In contrast,
a large deletion in the AHR transactivation domain (Pohjanvirta et al.,
1998) induces remarkable resistance to TCDD (LD50>10,000 μg/kg) in
H/W rats (Unkila et al., 1994). However, in spite of this mutation, H/W
rats remain responsive to TCDD treatment: for example, thymic atrophy
occurs in both L-E andH/W rats after TCDD-exposure (Pohjanvirta et al.,
1989; Tuomisto et al., 1999; Viluksela et al., 2000). Responses that are
similar in sensitive and resistant strains are termed “Type-I” responses,
while those that differ, such as acute lethality, are known as “Type-II”
responses (Pohjanvirta et al., 2011; Simanainen et al., 2002, 2003).
These pathologic differences are also evident at the molecular level:
many AHR-regulated genes such as Cyp1a1, Cyp1a2, and Nqo1 respond
equally in sensitive and resistant rats (Boutros et al., 2011; Moffat et
al., 2010).
Previously,we identiﬁed transcriptional changes that are concurrent
with the onset of dioxin toxicities by contrasting mRNA abundances in
mice and rats treated with TCDD (Boutros et al., 2008). We found very
dramatic inter-species heterogeneity, with approximately 90% of
dioxin-responsive genes being species-speciﬁc. Similarly, when we
compared dioxin-sensitive L-E versus dioxin-resistant H/W rats 19,
96, and 240 h following exposure to TCDD (Boutros et al., 2011;
Moffat et al., 2010), we found that the vast majority of genes exhibited
altered mRNA abundances in only one rat strain (Boutros et al., 2011;
Moffat et al., 2010).
Here, we extend our previous studies by considering six rat
strains/lines: H/W, L-E, line-A, line-C, Fischer 344 (F344) and Wistar
(Wis) rats. Lines A and C are derived from F1 crosses of H/W×L-E
rats (Tuomisto et al., 1999). F344 rats are moderately resistant to
TCDD but their LD50 values vary depending on the supplier (from
164 to 340 μg TCDD/kg body weight) (Walden and Schiller, 1985).
Wis rats, on the other hand, exhibit a mixed population of AHR geno-
types, consisting of either AHRwt/wt, AHRwt/hw, or AHRhw/hw. Wis rats'
sensitivities to TCDD vary according to the genotype that they carry
(Kawakami et al., 2009). All the Wis rats employed in the present
study were of the homozygous wildtype AHR genotype and are thus
more sensitive than H/W rats (see Methods). Our goals here are
two-fold. First, we survey for the ﬁrst time the inter-strain heteroge-
neity of rat transcriptomic responses to TCDD within a singleconsistent experiment. Second, we exploit the genetic diversity
amongst these rat strains to identify genes that show Type-I and
Type-II responses to TCDD. Type-I genes might regulate common
dioxin-induced toxicities in both sensitive and resistant rats; Type-II
genes are candidates to explain dioxin toxicities unique to sensitive
rats and not observed in resistant rats. We hypothesize that the genetic
“ﬁlter” imposed by inter-strain variability will facilitate identiﬁcation of
candidate genes for AHR-regulated toxicities.
Methods
Animal treatment. Male rats of four strains and two lines were ex-
amined: Long-Evans (L-E), Han/Wistar (Kuopio) (H/W), Fischer 344
(F344), Wistar (Wis), Line-A (LnA) and Line-C (LnC). Animals were
either treated with 100 μg/kg TCDD or corn-oil vehicle (4 mL/kg by
gavage) at the age of 11–15 weeks. The treatment dose chosen is le-
thal to all animals in dioxin-sensitive strains but not to any animals
in dioxin-resistant strains (Fig. 1) (Pohjanvirta and Tuomisto, 1994;
Tuomisto et al., 1999; Walden and Schiller, 1985). We conﬁrmed
that all Wistar animals possessed wild-type AHR by PCR analysis of
liver cDNA as previously described (Pohjanvirta, 2009). The rats
were housed singly in stainless steel wire-mesh cages and given ac-
cess to R36 feed (Ewos, Södertälje, Sweden) and water. Animals
were fed during the early light hours daily. Artiﬁcial illumination
was provided in the rooms with light and dark cycles every 12 h
with lights on daily at 07:00. The room temperature was maintained
at 21.5±1 °C and humidity at 55±10%. In total, 208 animals (56 for
microarray only and the remaining 152 for PCR validation) were used.
Animals in the microarray experiments were euthanized 19 h after
treatment with TCDD or corn oil vehicle. Animals in the time-course
experiments were given either 100 μg/kg TCDD or corn-oil vehicle
and their liver excised at different time intervals (from 0 to 384 h)
and animals in the dose–response experiments were treated with dif-
ferent doses of TCDD (from from 0 to 3000 μg/kg) or corn-oil vehicle
and their livers removed at 19 h post-treatment. Samples excised
from time-course and dose–response experiments were used for sub-
sequent PCR validation. Approval from the Animal Experiment Com-
mittee of the University of Kuopio and the Provincial Government of
Eastern Finland was obtained for all animal study plans.
Microarray hybridization. Following euthanasia, liver tissues were
excised, sliced, and snap-frozen. The tissues were later homogenized
and total RNA was extracted using Qiagen RNeasy kits according to
the manufacturer's instructions (Qiagen, Mississauga, Canada) as pre-
viously described (Boutros et al., 2011). The isolated RNAwas assayed
on Affymetrix RAT230-2 (Wis and F344; performed with six biological
replicates each) or RAE230-A (L-E, H/W, LnA, and LnC; performed
with four biological replicates each) arrays at The Centre for Applied
Genomics at The Hospital for Sick Children (Toronto, Canada). The
two platforms RAT230-2 and RAE230-A differ by the number of
probe sets contained on the array. The platform RAE230-A is a subset
of RAT230-2 and hence shares many of the same genes as RAT230-2.
Our statistical comparisons were performed within the same plat-
form; thus any variability is balanced and no bias is introduced. We
rigorously assessed the technical quality of each array and none
were excluded from subsequent data analyses. Animal handling
and reporting comply with ARRIVE guidelines (Kilkenny et al., 2010).
Microarray data pre-processing and statistical analysis. Raw quanti-
tated array data (CEL ﬁles) were loaded into the R statistical environ-
ment (v2.12.2) using the affy package (v1.28.0) of the BioConductor
library (Gentleman et al., 2004). Data were screened for spatial and
distributional homogeneity and none were excluded from this study.
Data were pre-processedwith a sequence-speciﬁc version of RMA algo-
rithm –GCRMA – as implemented in R (gcrma package v2.22.0). Probes
were remapped to Entrez Gene IDs using rat2302rnentrezgcdf (v13.0.0)
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Fig. 1. Experimental design. We analyzed responses of Long-Evans (Turku A/B) (L-E), Han/Wistar (Kuopio) (H/W), Fischer344 (F344), and Wistar (Wis), Line-A (LnA), Line-C (LnC)
rats. Animals were treated with either 100 μg/kg TCDD or corn-oil vehicle. After 19 h, the animals were euthanized and their livers excised and RNA extracted. Samples from F344
andWis rats were hybridized onto Affymetrix RAT230-2 microarrays and those from L-E, H/W, LnA, and LnC rats onto Affymetrix RAE230-A microarrays. A total of 65 animals were
studied. The number of animals for each strain or line is shown. The resulting data underwent a variety of statistical analyses including unsupervised machine learning, statistical
modeling, functional analysis and TFBS enrichment analysis as described in Methods.
137C.Q. Yao et al. / Toxicology and Applied Pharmacology 260 (2012) 135–145and rae230arnentrezgcdf (v13.0.0) R packages (Dai et al., 2005). Entrez
Gene annotationwas downloaded fromNCBI on 2011-02-22. Individual
strains were treated as separate cohorts and animals within a cohort
were pre-processed together to avoid confounding effects from co-
normalization of diverse strains. Raw and pre-processed microarray
data are available in the GEO repository under accession GSE31411.
Following pre-processing, we employed general linear-modeling
to identify genes affected by TCDD treatment relative to the vehicle
control. The expression proﬁles across all animals within a cohort
were determined using a per-gene linear model that assesses both
basal levels and TCDD-induced effects. Coefﬁcients were ﬁt to terms
representing each effect and the standard errors of the coefﬁcients
were adjusted using an empirical Bayes moderation of the standard
error (Smyth, 2004). To test if each coefﬁcient was statistically different
from zero, we applied model-based t-tests, followed by a false-
discovery rate adjustment for multiple-testing (Storey and Tibshirani,
2003). A full list of genes that are common between the two platforms
and their ﬁtted coefﬁcients is shown in Supplementary Table 1. Formost downstream analyses, genes were deemed statistically signiﬁcant
if the multiple-testing-adjusted probability that they were falsely-
deemed altered by TCDD (i.e. α, the false-positive probability) was
below that of our positive control gene, Cyp1a1, in any of the rat strains.
Thus our effective p-value threshold was the maximum adjusted
p-value observed for the well-characterized dioxin-responsive gene
Cyp1a1. All statistical analyses were performed in the limma package
(v3.6.9) for the R environment (v2.12.2).
Visualization. Unsupervised agglomerative hierarchical clustering
with complete linkage was employed to visualize patterns in mRNA
expression across rat strains, using Pearson's correlation as the
similarity metric. The lattice and latticeExtra packages were used
for visualization (v0.19–24 and v0.6–15 respectively) in the R sta-
tistical environment (v2.12.2). Venn diagrams were created using
the VennDiagram R package (v1.0.0) (Chen and Boutros, 2011).
We applied the hypergeometric test to assess statistical signiﬁ-
cance of gene overlaps.
Table 1
Genes for PCR validation.
A list of 6 genes was selected from this study to be carried forward into PCR validation. Here, coefﬁcients represent the fold-change of expression in log2 scale. The genes chosen
showed signiﬁcant responsiveness in all four strains or only in the sensitive strains after treatment with TCDD for 19 h. Further, they all have changes in mRNA abundances that are
at least 2-fold.
Gene
ID
Symbol Long-Evans rats Han/Wistar rats Fischer 344 rats Wistar rats Name
Coefﬁcient p Coefﬁcient p Coefﬁcient p Coefﬁcient p
85332 Prkcdbp 2.05 7.36×10−3 1.85 7.50×10−2 1.45 9.28×10−4 1.91 3.03×10−2 Protein kinase C, delta binding protein
64045 Glrx1 1.71 3.43×10−4 1.74 2.95×10−2 1.97 1.55×10−4 1.52 9.16×10−3 Glutaredoxin 1
24162 Acp2 1.55 4.39×10−3 1.41 6.39×10−2 1.35 2.70×10−6 1.06 3.85×10−3 Acid phosphatase 2, lysosomal
298652 Ube4b 1.61 8.38×10−4 1.13 3.32×10−2 1.42 3.13×10−2 1.4 8.26×10−3 Ubiquitination factor E4B (UFD2 homolog, yeast)
29573 Slc37a4 −1.36 1.71×10−2 −1.01 1.57×10−1 −1.03 1.47×10−2 −1.61 5.29×10−2 Solute carrier family 37 (glucose-6-phosphate
transporter), member 4
25216 Sdc1 −2.07 2.27×10−2 −0.59 5.21×10−1 −1.41 7.06×10−3 −1.76 2.49×10−2 Syndecan 1
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software (Zeeberg et al., 2003). We used build 269 of the GOMiner
application, with database build 2009-09. We checked our genes of
interest against a randomly drawn sample from the dataset with a
false discovery rate (FDR) threshold of 0.1, 1000 randomizations, all
rat databases and look-up options, all GO evidence codes and ontologies
(molecular function, cellular component and biological process) and a
minimum of ﬁve genes for a GO term. Separate ontological analyses
were run for genes differentially expressed in each rat strain. Subse-
quently, RedundancyMiner (Zeeberg et al., 2011) was used to de-
replicate enriched GO categories and to reﬁne pathway analysis. A
CIM ﬁle generated from GOMiner was loaded into R statistical environ-
ment (v2.13.1). Input ﬁles for RedundancyMiner were created by
concatenating categories when FDR≤0.20 in at least 4 strains. This re-
laxed p-value threshold was chosen to allow for biological variability
between strains; the emphasis on at least 4 strains allowed the genetic
model to form the primary ﬁlter, while allowing ﬂexibility for biological
variability and allowing for false negatives. There are two parameters
used to collapse the matrix: compression and biological interpretation.
Generally, more permissive p-values offer greater compression but
can concatenate many of the same GO categories into different
groups, thereby producing another type of redundancy. For each
dataset, p-values were empirically chosen to ensure sufﬁcient
compression that GO categories with biological functions could
be interpreted correctly. Based on these selection criteria, 32 GO
categories were chosen. The input matrix was collapsed to obtain
20 ﬁnal categories and a compression ratio of 1.60. Visualization
of RedundancyMiner results was done using lattice package
(0.19-31) for R (v2.13.1).Transcription-factor binding site analysis. To determine if changes
in mRNA expression levels were associated with differences in tran-
scription factor binding sites (TFBS) (Wasserman and Sandelin,
2004), we conducted motif-recognition analysis by searching −10
kbp to +5 kbp region from our signiﬁcantly altered genes against
AHRE-I (core), AHRE-I (extended), AHRE-I (full), and AHRE-II, with
sequences: GCGTG (Denison and Whitlock, 1995), TNGCGTG
(Denison and Whitlock, 1995), [T|G]NGCGTG[A|C][G|C]A (Denison
and Whitlock, 1995), and CATG{N6}C[T|A]TG (Sogawa et al., 2004),
respectively. Genes were annotated with transcription start-site
(TSS) using REFLINK and REFFLAT tables downloaded from the UCSC
genome browser data on August 23, 2010 (Karolchik et al., 2003).
Within each AHRE-motif, a PhyloHMM conservation score was calcu-
lated across different species. The scores vary from 0 to 1, with a score
of 0 meaning that there is a minimal conservation and 1 meaning that
there is a strong conservation. Motifs that are evolutionarily well con-
served are particularly likely to be functional (Siepel and Haussler,
2004).PCR quantitation of selected genes. Primers and probes were
designed using the real-time PCR Assay Design Tool on the Integrated
DNA Technologies (IDT, Coralville, IA) website (http://www.idtdna.
com/Scitools/Applications/RealTimePCR). To ensure speciﬁcity, pro-
bes were compared with Rattus norvegicus nr/nt database using nu-
cleotide Basic Local Alignment Search Tool (BLAST). Similarly,
primer pairs were compared to the same database using Primer
BLAST (http://www.ncbi.nlm.nih.gov/blast) (Altschul et al., 1990,
1997). Total RNA samples were reverse transcribed using the High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems). In ad-
dition, for each reverse-transcribed sample, a similar preparation was
made where all the reagents were included except for the reverse
transcriptase. The above reactions were conducted with 1 μg of RNA
as outlined in the manufacturer's instruction. PCR reactions were pre-
pared with 5 ng of cDNA using the TaqMan Gene Expression Master
Mix (Applied Biosystems) with gene-speciﬁc primers/probes
(Table 1). A total of 84 biological replicates were analyzed for H/W
rats and 68 replicates for L-E rats, each performed with two technical
replicates in a 10 μL reaction volume. PCR reactions were run on the
7900HT Fast Real-Time PCR System (Applied Biosystems) using de-
fault settings for relative quantiﬁcation calculated from comparative
Ct values. qPCR results were then collected using Sequence Detection
System Software v2.3 (Applied Biosystems) and the quantitated data
were loaded into the R statistical environment (v2.12.2). These data
were then processed and normalized as previously described
(Barsyte-Lovejoy et al., 2006) using the previously validated house-
keeping genes Gapdh and Pgk1 (Pohjanvirta et al., 2006). Normalized
data were log2-transformed and visualized across the different doses
and time points tested for both L-E and H/W rats. ANOVAs were used
to identify differences in expression between the strains across all
time-points and doses. Student's t-tests were performed post hoc
when pANOVAb0.1.
Results
Animal models
In previous studies we examined two rat strains (L-E and H/W)
and two inbred lines (LnA and LnC) derived from L-E×H/W crosses
(Boutros et al., 2011; Franc et al., 2008; Moffat et al., 2010). Here
we expand our search for association genes responsible for mediating
dioxin-sensitivity phenotypes by including two other rat strains with
wildtype AHR (and greater dioxin sensitivity than H/W rats). These
strains – Fischer 344 (F344) and Wistar (Wis) –were selected because
of their wide use in toxicology and pharmacology. We previously
showed that mRNA abundances vary substantially between sensitive
and resistant rat strains at late time-points (4 and 10 days post treat-
ment) (Boutros et al., 2011), so we designed our current experiment
to examine the effects of TCDD at a time consistent with the onset of
Fig. 2. Transcriptomic summary. A) We visualized the fold-changes using unsupervised
machine-learning to identify innate patterns within the dataset. Each row represents a
strain and each column represents a gene. The red-to-blue scale at the bottom repre-
sents the fold-changes, going from repression to induction. We applied a padjusted
cut-off of 0.01. Rats that possess wild-type AHR (L-E and LnC), have similar sensitivity
to TCDD and cluster tightly on the heatmap while resistant rats (H/W and LnA) cluster
together. B) We next looked at the inter-strain correlation of fold-changes at the same
padjusted threshold. Shading in the bottom panel represents the correlation (white is
low correlation and blue is high). Again, we see clustering amongst rat strains that
have similar sensitivities to TCDD toxicity. Further, the fold-changes between different
rat strains/lines overall are highly correlated.
BA
C
L-E 1142
H/W 198 270
F344 456 154 1197
Wis 178 89 242 329
LnA 396 150 247 106 565
LnC 425 162 313 134 278 692
L-E
H/W
F344
W
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D
Fig. 3. Inter-strain variability. A) We ﬁrst examined the percentage of genes signiﬁcantly
altered by TCDD in each rat strain at different p-value cut-offs. The greatest number of
changes was observed in L-E rats, independent of the threshold selected. H/W rats
displayed the fewest gene responses to TCDD. Other rat strains showed intermediate
numbers of responses. B)We then assessed the number of responsive genes across rat
strains. The number of responsive genes decreases as the number of strains increases.
C) After addressing how many genes were responsive to TCDD within each strain, we
determined the number of responsive genes between or across strains. We applied a
padjusted cut-off that equals to the maximum p-value across all strains for Cyp1a1, a
classic TCDD-induced gene. A set of 11 genes showed signiﬁcant responses across
all strains. D) Outside of this core, genes vary signiﬁcantly across strains in their re-
sponses to TCDD.
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sistant strains (100 μg/kg; Fig. 1).Overall transcriptomic responses to TCDD in the strains
Following data pre-processing and linear modeling, we ﬁrst eval-
uated our dataset using unsupervised machine-learning to identify
the strongest trends within the dataset in an unbiased way (Boutros
and Okey, 2005). We applied an adjusted p-value threshold of 0.01
to remove genes that showed small or no differential expression in
response to TCDD. We found that rat strains clustered togetheraccording to their dioxin sensitivity (Fig. 2A). Sensitive L-E and LnC
clustered tightly together on the heatmap, as do the resistant H/W
and LnA resistant pair of strains and the F344 and Wis rats are of in-
termediate sensitivity and also cluster together. Thus, the strongest
trend in gene expression changes after a single high dose of TCDD is
dioxin-sensitivity rather than general inter-strain variability. We
also examined the correlation of gene expression between all possible
pairings of rat strains and again found that strains with similar
dioxin-sensitivity shared similar patterns and clustered tightly to-
gether (Fig. 2B).
This type of co-clustering could be caused by either a small global
alteration in a large number of genes or by large changes in a small
number of genes. To assess which of these two possibilities was occur-
ring, we asked what fraction of genes was signiﬁcantly altered by TCDD
exposure in each rat strain. To do so in a threshold-independent man-
ner, we evaluated the number of changes at different p-value cut-offs
(Fig. 3A). The highest number of genes altered was observed in L-E
rats (blue curve), followed by F344 rats (purple curve). Wis and H/W
rats showed the smallest number of TCDD-responsive genes (yellow
and light green curves, respectively). LnC (dark green) and LnA (red)
were intermediate amongst the other strains. All effects were inde-
pendent of the p-value threshold, indicating that the variation in
the number of responsive genes across strains is a real biological
phenomenon, not an artifact of statistical methodology.
These data indicate that large magnitude changes in a small num-
ber of genes probably accounted for the co-clustering seen in Fig. 2.
To determine the overlap of these TCDD-responsive genes across
the different strains/lines, we analyzed the number of responsive
genes across strains. We merged the data from RAT230-2 and
RAE230-A microarrays by keeping genes common to both and visual-
ized those that were TCDD-responsive (Fig. 3B). There is a log-
decrease in the number of responsive genes as the number of strains
Fig. 4. Dotmap of TCDD-responsive genes. A) We focused on the 11 genes with con-
served responses across all four rat strains and visualized their mRNA abundances in
log2-scale using a dotmap. These include genes that are well-known AHR-regulated
genes, including cytochromesP450, ubiquitination factors, andglutaredoxin. B) Conversely,
we identiﬁed a set of 11 genes that showed signiﬁcant responses in L-E, F344, andWis rats
but not in the resistant H/W rats. All genes showed the same direction of change, but the
magnitude of changes varied signiﬁcantly amongst the different strains. The size of the cir-
cle corresponds to themagnitude of the fold-change and the colours represent up- (red) or
down- (blue) regulation. Shading in the background represents adjusted p-values in -log10
scale with gray having an adjusted p-value of 10–6 and white as a value of 1.
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of TCDD-responsive genes. We found a set of 11 genes that responded
signiﬁcantly to TCDD in all six strains/lines (Fig. 3C). Outside of this
core, strains differ signiﬁcantly in their responses to TCDD and there
is minimal overlap between them (Fig. 3D). Interestingly, F344 rats
showed greater similarity to L-E rats (25.3% overlap) than to H/W
rats (9.8% overlap); Wis rats had similar numbers of gene alterations
as H/W rats but greater similarity in speciﬁc genes to L-E (41.8% overlap)
than to H/W rats (22.4% overlap).Conserved transcriptomic responses to TCDD
We previously contrasted the transcriptomic responses to TCDD
between L-E and H/W rats at 4 and 10 days following TCDD treatment
at 100 μg/kg and found considerable overlap between the two strains
at both time points (Boutros et al., 2011). Similarly, we looked for
overlap between different rat strains at an early time point (19 h) to
identify genes that may have critical roles in triggering TCDD toxicity.
Consistent with our previous data, the 11 genes that exhibited the
greatest magnitude of response and were most consistent across all
6 strains/lines at the onset of TCDD toxicity are classic
AHR-regulated genes, such as Cyp1a1, Cyp1b1, Nqo1, and Tiparp. All
11 of these genes exhibited consistent directions and magnitudes of
change across all six strains and lines (Fig. 4A).
Responses to TCDD that are speciﬁc to sensitive rats
We hypothesized that genes showing differential gene expression
between sensitive and resistant rat strains are strong candidates to
mediate susceptibility to dioxin lethality. To test this hypothesis, we
focused on genes that showed divergent responses between rat
strains with differing TCDD-sensitivity. We identiﬁed genes that
were altered speciﬁcally in highly or moderately TCDD-sensitive L-E,
F344, and Wis rats but not in resistant H/W rats (Fig. 4B). Here we
see that although multiple genes showed the same directionality of
change across all 6 strains, there are differences in the magnitude of
response across the different strains, with some genes having a
4-fold difference in gene expression between strains.
Functional analysis of TCDD-responsive genes
To examine whether genes identiﬁed from the above analysis be-
long to a speciﬁc pathway, perhaps leading to conserved strain-
independent TCDD toxicity, we employed functional analysis for the
100 genes that showed the smallest adjusted p-values for each strain.
We examined GO terms that have FDR of less than or equal to 0.01
and visualized their overlap across different rat strains (Fig. 5A for
statistical signiﬁcance; Fig. 5B for enrichment). Processes that pertain
to oxidation–reduction were commonly dysregulated in L-E, H/W,
LnA, and LnC rats but not in F344 and Wis rats, perhaps implying dif-
ferent mechanisms that animals possess for handling TCDD. By con-
trast toxin metabolic processes were signiﬁcantly enriched across all
six strains, and many core TCDD-responsive genes (e.g. Cyp1a1) lie
within this highly enriched category.
In order to gain additional insight into the functional processes of
the candidate genes, we performed RedundancyMiner analysis. Re-
dundant GO categories were eliminated and parent categories were
weighted to prevent over-representation. Redundant GO terms
were collapsed into groups; GO categories that were recognized as
statistically signiﬁcant from GOMiner analysis were also signiﬁcant
after application of RedundancyMiner. Oxidoreductase activity and
toxin metabolic process showed signiﬁcant enrichment before and
after RedundancyMiner analysis (FDRb0.01), indicating the robust-
ness of the results (Fig. 5C).
Transcription factor binding site analysis
To provide additional mechanistic insight into how this functional
diversity of TCDD responses is generated, we hypothesized that a
small number of transcriptional regulators were at play. We therefore
analyzed the occurrence of transcription factor binding sites (TFBSs)
in TCDD-responsive genes using enrichment analysis as previously
described (Boutros et al., 2011). We plotted the number of occur-
rences and the maximal conservation scores of each motif against
the number of rat strains in which the gene was affected by TCDD
treatment. AHRE-I has been found to reside on common AHR-
Fig. 5. Functional analysis. To assess whether genes that responded to TCDD within each rat strain might be regulated by a common pathway, we selected the top 100 genes from
each rat strain that have the smallest adjusted p-values and ran them through GO Miner (see Methods section for selection parameters used). A) The majority of the GO categories
were signiﬁcantly enriched in L-E, H/W, LnA, and LnC but not in F344 andWis rats (left panel). Of the signiﬁcantly expressed GO categories, toxinmetabolic process and dibenzo-p-dioxin
metabolic process showed the highest enrichment (right panel; GO terms clustered according to left panel data). B) To further investigate pathways involved in dioxin toxicities, we
employed RedundancyMiner, a tool that dampens the over-representation of speciﬁc GO terms. We collapsed our 32 GO categories into 20 functional groups. The row-annotation
table represents the number of GO categories that were grouped into each functional group (going fromwhite to dark blue: 1 to 8 categories). A number of processes that react to toxins
or toxicants showed consistently signiﬁcant enrichment before and after the application of RedundancyMiner; these include dibenzo-p-dioxinmetabolic process, toxinmetabolic process,
oxidoreductase activity, and catalytic activity.
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complex and enhances transcription. More recently, several studies
have revealed that the AHRE-II motif aids transcription of Cyp1a2and some other TCDD-responsive genes (Boutros et al., 2004;
Sogawa et al., 2004). We analyzed the number and conservation of
each motif across the strains (Figs. 6A–D). AHRE-I motifs were
Fig. 6. TFBS analysis. We performed a TFBS enrichment analysis that assesses the match between our genes of interest and the occurrence of 4 different motifs: A) AHRE-I (core);
B) AHRE-I (extended); C) AHRE-I (full); and D) AHRE-II (the sequence for each is described in Methods). The genes were selected at a Padj threshold equaling to the maximum Padj
of Cyp1a1 as described in Methods. We then visualized both the counts and conservation scores in all genes of interests across different numbers of rat strains; that is, 0 represents
genes that are not signiﬁcantly altered across any number of rat strains and 6 represents genes that are responsive to TCDD across all six rat strains. We found that AHRE-I was
conserved in genes that were signiﬁcantly altered by TCDD in all six rat strains whereas AHRE-II was not conserved in responsive genes across strains.
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strains, whereas AHRE-II motifs were not conserved across the rat
strains that we tested.
Validation of TCDD-responsive genes
Finally, to examine potential roles of the selected genes inmediating
TCDD toxicity and to check whether the responsiveness of these genes
is regulated in a time- or dose-dependentway, we conducted PCR anal-
ysis on six genes across 152 animals (84 H/W rats and 68 L-E rats) in
both time-course (from 0 to 384 h) and dose–response experiments
(from 0 to 3000 μg/kg). Experiments involving different time points
were used to determinewhether the genes exhibit acute or downstream
effects; dose–response experimentswere used to observe patterns of ex-
pression with increasing dose that might relate to doses that evoke he-
patic toxicity. The genes analyzed by PCR showed signiﬁcant mRNA
abundance changes with a magnitude of 2-fold or larger in response to
TCDD either in all rat strains or in all sensitive rat strains. Aside from
Sdc1, all of the selected genes showed both time-dependent and dose-
dependent responses to TCDD (Fig. 7). As expected, we observed fewer
differences in the expression of the tested genes in the dose–response
experiments than in the time-course experiments due to the short dura-
tion of exposure (19 h). Results from Sdc1were not interpretable due to
a discrepancy between the time- and dose–response. However, of the
ﬁve genes that showed time- and dose-dependent responses, Acp2,
Glrx1, Slc37a4, and Ube4b showed differential responses to TCDD be-
tween L-E and H/W rats around and after the onset of TCDD toxicity
(19 h post-treatment), potentially suggesting their roles in determining
sensitivity or resistance to TCDD.
Discussion
We previously compared transcriptomic responses of sensitive L-E
rats to those of resistant H/W rats in response to TCDD. Liver samples
were collected at 19, 96 or 240 h post treatment to allow comparisonof changes in mRNA abundances around or after the onset of toxicity
(Boutros et al., 2011; Moffat et al., 2010). In the current study, we
expanded this comparison by including additional rat strains that
are moderately sensitive to TCDD, F344 and Wis. The two main
goals of this study were to identify transcriptomic responses that
are conserved across rat strains along with responses that differ
between sensitive and resistant strains at a time near the onset
of the ﬁrst manifestations of TCDD toxicity. TCDD-induced toxic-
ities include hepatic lesions, endocrine imbalances, immunosup-
pression, and wasting syndrome (reviewed in Pohjanvirta and
Tuomisto, 1994).
Our results show that the vast majority of dioxin-induced changes
in mRNA abundances are not conserved across strains, at least in liver,
and at dose of 100 μg/kg and exposure time of 19 h. One mechanistic
explanation for AHR activity is the “classic action pathway” wherein
TCDD binds to the AHR and elicits a series of downstream effects
which ultimately results in the activation of transcription of AHR-
regulated genes such as Cyp1a1, Cyp1a2, etc. (Okey, 2007). Recently,
some groups have proposed an alternative mechanism of the AHR's
involvement in TCDD toxicity, particularly inﬂammatory responses,
in a ligand-independent way. The ligand-independent pathway does
not involve the presence of ARNT and is said to be “non-genomic”
(Dong and Matsumura, 2008; Li and Matsumura, 2008; Li et al.,
2010; Sciullo et al., 2008). Our data support the “classic action path-
way” as the main mechanistic determinant of AHR toxicity, as those
few genes consistently altered by TCDD across strains are signiﬁcantly
enriched for AHR DNA binding-motifs.
The set of common AHR regulated genes that showed differential
expression amongst multiple rat strains and at multiple doses and
time-points includes common dioxin responsive genes such as
Cyp1a1, Cyp1a2, Cyp1b1, Tiparp, and Nqo1. These genes might partially
explain some of the Type-I responses to TCDD that are observed in
both sensitive and in resistant animals. Amongst the other genes,
Ube4b was shown to be responsive to TCDD across all four rat strains
as well as the two lines, LnA and LnC. Ube4b encodes for an
Fig. 7. PCR validation using time-course and dose–response experiments. Finally, to verify
if the novel TCDD-responsive genes identiﬁed in this study (Table 1) are candidates to
mediate speciﬁc TCDD toxicities, we studied their A) time-course and B) dose–response.
The time of exposure ranges from 0 to 16 days (shown in log10 scale). L-E and H/W rats
were treated with either 100 μg/kg TCDD or corn-oil vehicle for each time point in the
time-course study. Five of the six genes displayed classic time-course response where
the fold-change increases with prolonged time of exposure. Results from our dose–
response experiments are shown in B). The doses range from0 to 3000 μg/kg and animals
were uniformly treated with TCDD or corn-oil vehicle and liver collected 19 h following the
treatment. Interestingly all ﬁve genes that exhibited a time-course response also showed a
dose-dependent change in mRNA levels.
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celerates ubiquitin chain assembly in synchronywith factors E1, E2, and
E3,which subsequently tags aberrant proteins for degradation (Koegl et
al., 1999). We found that Ube4b is consistently dysregulated by TCDD
treatment (2-fold induction). It is unclear what role it plays in dioxin
toxicity but it could be a protective mechanism that is elicited in re-
sponse to exposure to xenobiotics. Interestingly, the AHR was recently
shown to act as a ligand-dependent ubiquitin E3 ligase targeting e.g.
sex hormone receptors and β-catenin for proteasomal degradation
(Ohtake and Kato, 2011).Glrx1, another gene whose mRNA abundances were statistically
different between the treated and untreated rats across all four rat
strains, is a glutaredoxin that catalyzes deglutathionylation of
protein-SS-glutathione mixed disulﬁdes. Glrx1 was induced more
than 2-fold across all rat strains and lines. It is involved in protecting
cells against oxidative stress (Terada et al., 2010); up-regulation of
Glrx1 may be a protective mechanism since other studies have also
suggested its potential role in regulating apoptosis in cardiomyocytes
(Gallogly et al., 2010) and controlling autocrine and paracrine proin-
ﬂammatory responses in retinal glial cells (Shelton et al., 2009). Since
L-E rats, which are much more sensitive to TCDD-induced liver tumor
promotion than H/W rats (Viluksela et al., 2000), exhibited an up-
ward trend in Glrx1 expression at the latest time-points analyzed
(Fig. 7), dysregulation of Glrx1 might have a role in the hepatocarci-
nogenicity of TCDD in rats. On the other hand, the enhanced Glrx1 ex-
pression coincides with aggravation of lipid peroxidation (an index of
oxidative stress) in lethally TCDD-treated L-E rats (Pohjanvirta et al.,
1990).
Another trend that was also consistent with our previous ﬁnding
is that outside of the set of “classic” AHR-responsive genes, genes
vary signiﬁcantly in their responses to TCDD across the different rat
strains. We identiﬁed a set of genes whose expression was signiﬁ-
cantly altered by TCDD in the sensitive rat strains but not the resistant
H/W rats. These genes may represent predisposing genes that give
rise to the observed toxicities to TCDD as mentioned above in the sen-
sitive strains. For example, Slc37a4 encodes a transporter protein that
transports glucose-6-phosphate to the microsomal lumen where
hexose-6-phosphate dehydrogenase hydrolyses it to glucose and in-
organic phosphate (Pi) (Marcolongo et al., 2007). Deﬁciencies in the
protein have been associated with disturbed glucose homeostasis
and glycogen storage diseases (Chou et al., 2002; Pan et al., 2009).
In our experiment, Slc37a4 was signiﬁcantly down-regulated by
2-fold in the sensitive rat strains but not in the resistant H/W rats.
This is consistent with our previous ﬁnding where H/W rats showed
minimal or no change in body weight following TCDD treatment
whereas signiﬁcant weight loss was observed for the sensitive L-E
strain after both time points (Boutros et al., 2011), as is amore prominent
decrease in plasma glucose upon TCDD treatment in L-E than H/W rats
(Viluksela et al., 1999). Dysregulation of Slc37a4 could be involved in
the differential energy and feedmetabolism between sensitive and resis-
tant strains and the resultingwasting syndromeobserved in the sensitive
strains but not in resistant strains (Boutros et al., 2011; Pohjanvirta and
Tuomisto, 1994).
Endocrine imbalance is another acute effect that follows TCDD
treatment (Pohjanvirta and Tuomisto, 1994). Some portion of endo-
crine disruption may be due to altered synaptic transmission and
communication from neurons to the endocrine system. Acp2, a gene
that is consistently induced by 2-fold in the sensitive strains but not
in the resistant strain, encodes a lysosomal acid phosphatase that cat-
alyzes p-nitrophenyl phosphate hydrolysis. The abundance of the
phosphatase in the nerve endings suggests its potential role in synap-
tic transmission (Tanino et al., 1999). In other studies, Acp2was found
to play a role in acute pancreatitis (Lakowska et al., 2001). It is difﬁ-
cult to evaluate the role of Acp2 in TCDD toxicity due to the insufﬁ-
cient characterization of its physiological functions, but the increase
in Acp2 expression may have a role in the imbalance in the endocrine
system of rats that are exposed to TCDD (Pohjanvirta and Tuomisto,
1994).
Long-term exposure to TCDD leads to cancer formation in liver
and other organs (Viluksela et al., 2000). Prkcdbp encodes a protein
kinase-binding protein that may be involved in the control of cell
growth mediated by protein kinase C (Izumi et al., 1997). Prkcdbp
showed greater than 3-fold induction in the sensitive strains but did
not reach statistical signiﬁcant in the resistant H/W strain. Impaired
control of cell growth could well contribute to the carcinogenic effect
of TCDD in sensitive animals. On the other hand, Sdc1, amouse homolog
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sion by at least 3-fold in all the sensitive strains but remained unper-
turbed in the resistant H/W strain. Sdc1 has been previously shown to
be implicated in hepatocellular cancer (HCC). Both the gene and protein
expression of Sdc1was signiﬁcantly reduced in HCC with extra-hepatic
metastasis in comparison with those without (Matsumoto et al., 1997).
This suggests that Sdc1 may play a role in determining metastatic
potential.
A highly characteristic feature of the acute toxicity of TCDD is its
delayed emergence. Even after supralethal doses of TCDD, the ex-
posed animals do not die immediately but only after 2–5 weeks
(Pohjanvirta and Tuomisto, 1994). Therefore, it is conceivable that
the critical phase of TCDD toxicity that differs between sensitive and
resistant animals is not – in contrast to the case of many other toxi-
cants – the early primary response but rather its later repercussions.
This view would be in keeping with the poor segregation of changes
in individual gene expression levels with TCDD sensitivity in the pre-
sent study. We recently also showed that the number of dissimilar
transcriptomic responses between L-E and H/W rats increases as a
function of time (Boutros et al., 2011).
TCDD exposure and subsequent toxicity are an important issue
that could directly affect human health. We focused our experiments
on liver tissue because there is extensive hepatotoxicity in rats fol-
lowing exposure to TCDD. The ultimate target organ for lethality re-
mains unknown; however, large hepatic differences exist in toxic
end-points between the sensitive L-E and the resistant H/W rats,
making liver a good candidate organ for involvement in systemic
TCDD toxicities.
The role of the AHR genotype in regard to liver toxicity is especially
well demonstrated in a study conducted by Pohjanvirta, where trans-
genic C57BL/6 mice that express the rat wild-type isoform of the AHR
showed signiﬁcantly higher expression of AHR and CYP1A1 in compar-
ison to non-transgenic mice, particularly in liver (Pohjanvirta, 2009).
That study also demonstrated that liver is a major target for TCDD's
toxic effects; hence, studying differential gene expression in liver is crit-
ical to the overall understanding of TCDD toxicity. By combining existing
genetic models with microarray analysis, we have identiﬁed key novel
candidate genes that are worthy of further investigation for differential
expression at the protein level and ultimately in mechanistic studies to
connect altered expression to subsequent overt toxicity.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.taap.2012.02.001.
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